Basic science of articular cartilage and osteoarthritis

Clinics in Sports Medicine

Volumn 24, Issue 1, 2005, Pages 1-12

  Pearle, Andrew D ^a   Warren, Russell F ^a   Rodeo, Scott A ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; MATRIX METALLOPROTEINASE; PROTEOGLYCAN; TUMOR NECROSIS FACTOR ALPHA; HYALIN;

ARTHRALGIA; ARTHROPATHY; ARTICULAR CARTILAGE; CHONDROMALACIA; CLINICAL TRIAL; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; JOINT CAVITY; JOINT STIFFNESS; OSTEOARTHRITIS; OSTEOPHYTE; REVIEW; BIOMECHANICS; HISTOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; WEIGHT BEARING;

BIOMECHANICS; CARTILAGE, ARTICULAR; HUMANS; HYALIN; OSTEOARTHRITIS; WEIGHT-BEARING;

EID: 14744305948     PISSN: 02785919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.csm.2004.08.007     Document Type: Review

References (63)

1. Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev 1988;10:1-28.
2. Felson DT, Zhang Y, Hannan MT, et al. The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study: the effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Arthritis Rheum 1995;38(10):1500-5.
3. Guccione AA, Felson DT, Anderson JJ, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health 1994;84(3):351-8.
4. Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000;133(8):635-46.
5. Mow VC, Proctor CS, Kelly MA. Biomechanics of articular cartilage. In: Nordin M, Frankel VH, editors. Basic biomechanics of the musculoskeletal system. Philadelphia: Lea & Febiger; 1989. p. 31-57.
6. Wong M, Wuethrich P, Eggli P, Hunziker E. Zone-specific cell biosynthetic activity in mature bovine articular cartilage: a new method using confocal microscopic stereology and quantitative autoradiography. J Orthop Res 1996;14(3):424-32.
7. Schumacher BL, Hughes CE, Kuettner KE, Caterson B, Aydelotte MB. Immunodetection and partial cDNA sequence of the proteoglycan, superficial zone protein, synthesized by cells lining synovial joints. J Orthop Res 1999;17(1):110-20.
8. Schumacher BL, Block JA, Schmid TM, Aydelotte MB, Kuettner KE. A novel proteoglycan synthesized and secreted by chondrocytes of the superficial zone of articular cartilage. Arch Biochem Biophys 1994;311(1):144-52.
9. Klein TJ, Schumacher BL, Schmidt TA, et al. Tissue engineering of stratified articular cartilage from chondrocyte subpopulations. Osteoarthritis Cartilage 2003;11(8):595-602.
10. Macirowski T, Tepic S, Mann RW. Cartilage stresses in the human hip joint. J Biomech Eng 1994;116(1):10-8.
11. Ateshian GA, Wang H. Rolling resistance of articular cartilage due to interstitial fluid flow. Proc Inst Mech Eng [H] 1997;211(5):419-24.
12. Soltz MA, Ateshian GA. Interstitial fluid pressurization during confined compression cyclical loading of articular cartilage. Ann Biomed Eng 2000;28(2):150-9.
13. Soltz MA, Ateshian GA. Experimental verification and theoretical prediction of cartilage interstitial fluid pressurization at an impermeable contact interface in confined compression. J Biomech 1998;31(10):927-34.
14. Mankin HJ, Mow VC, Buckwalter JA, Iannotti JP, Ratcliffe A. Articular cartilage structure, composition, and function. In: Buckwalter JA, Einhorn TA, Simon SR, editors. Orthopedic basic science: biology and biomechanics of the musculoskeletal system. Rosemont (IL): American Academy of Orthopaedic Surgeons; 1999. p. 444-70.
15. Maroudas AI. Balance between swelling pressure and collagen tension in normal and degenerate cartilage. Nature 1976;260(5554):808-9.
16. Bullough P. The dysfunctional joint. In: Bullough P, editor. Orthopaedic pathology. 4th edition. Philadephia: Mosby; 2004. p. 239-58.
17. Mankin HJ. The response of articular cartilage to mechanical injury. J Bone Joint Surg Am 1982;64(3):460-6.
18. Mankin HJ, Mow VC, Buckwalter JA. Articular cartilage repair and osteoarthritis. In: Buckwalter JA, Einhorn TA, Simon SR, editors. Orthopedic basic science: biology and biomechanics of the musculoskeletal system. Rosemont (IL): American Academy of Orthopaedic Surgeons; 1999. p. 472-88.
19. Akizuki S, Mow VC, Muller F, Pita JC, Howell DS. Tensile properties of human knee joint cartilage. II. Correlations between weight bearing and tissue pathology and the kinetics of swelling. J Orthop Res 1987;5(2):173-86.
20. Lai WM, Hou JS, Mow VC. A triphasic theory for the swelling and deformation behaviors of articular cartilage. J Biomech Eng 1991;113(3):245-58.
21. Setton LA, Mow VC, Muller FJ, Pita JC, Howell DS. Mechanical properties of canine articular cartilage are significantly altered following transection of the anterior cruciate ligament. J Orthop Res 1994;12(4):451-63.
22. Lyyra T, Kiviranta I, Vaatainen U, Helminen HJ, Jurvelin JS. In vivo characterization of indentation stiffness of articular cartilage in the normal human knee. J Biomed Mater Res 1999; 48(4):482-7.
23. Franz T, Hasler EM, Hagg R, Weiler C, Jakob RP, Mainil-Varlet P. In situ compressive stiffness, biochemical composition, and structural integrity of articular cartilage of the human knee joint. Osteoarthritis Cartilage 2001;9(6):582-92.
24. Bae WC, Temple MM, Amiel D, Coutts RD, Niederauer GG, Sah RL. Indentation testing of human cartilage: sensitivity to articular surface degeneration. Arthritis Rheum 2003;48(12):3382-94.
25. Wang H, Strauch RJ, Ateshian GA, Pawluck RJ, Xu L, Rosenwasser MP. Variations of compressive stiffness and thickness of the thumb carpometacarpal joint cartilage with degeneration and age. Orthopaedic Research Society 44th Annual Meeting, New Orleans (LA); March 16-19, 1998.
26. Chevalier X. Is a biological marker for osteoarthritis within reach. Rev Rheum 1997;64(10):562-76.
27. Wollheim FA. Serum markers of articular cartilage damage and repair. Rheum Dis Clin North Am 1999;25(2):417-32.
28. Lindhorst E, Vail TP, Guilak F, et al. Longitudinal characterization of synovial fluid biomarkers in the canine meniscectomy model of osteoarthritis. J Ortho Res 2000;18(2):269-80.
29. Bashir A, Gray ML, Hartke J, Burstein D. Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI. Magn Reson Med 1999;41(5):857-65.
30. Tiderius CJ, Olsson LE, Leander P, Ekberg O, Dahlberg L. Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in early knee osteoarthritis. Magn Reson Med 2003;49(3):488-92.
31. Wang JH, Jia F, Gilbert TW, Woo SL. Cell orientation determines the alignment of cell-produced collagenous matrix. J Biomech 2003;36(1):97-102.
32. Nieminen MT, Rieppo J, Toyras J, et al. T2 relaxation reveals spatial collagen architecture in articular cartilage: a comparative quantitative MRI and polarized light microscopic study. Magn Reson Med 2001;46(3):487-93.
33. Xia Y, Moody JB, Burton-Wurster N, Lust G. Quantitative in situ correlation between microscopic MRI and polarized light microscopy studies of articular cartilage. Osteoarthritis Cartilage 2001;9(5):393-406.
34. Maier CF, Tan SG, Hariharan H, Potter HG. T2 quantitation of articular cartilage at 1.5 T. J Magn Reson Imaging 2003;17(3):358-64.
35. Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest 1996;97(9):2011-9.
36. Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthritis Cartilage 2004;12(Suppl A): S31-3.
37. Lark MW, Bayne EK, Flanagan J, et al. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest 1997;100(1):93-106.
38. Tortorella MD, Pratta M, Liu RQ, et al. Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). J Biol Chem 2000;275(24):18566-73.
39. Choy EH, Isenberg DA, Garrood T, et al. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum 2002;46(12):3143-50.
40. Brandt KD, Mazzuca SA, Katz BP, Lane KA. Doxycycline (Doxy) slows the rate of joint space narrowing (JSN) in patients with knee osteoarthritis (OA). Late-breaking abstracts. Program and abstracts of American College of Rheumatology 67th Annual Scientific Meeting, Orlando (FL), October 23-28, 2003.
41. Chen CT, Bhargava M, Lin PM, Torzilli PA. Time, stress, and location dependent chondrocyte death and collagen damage in cyclically loaded articular cartilage. J Orthop Res 2003;21(5):888-98.
42. Lucchinetti E, Adams CS, Horton Jr WE, Torzilli PA. Cartilage viability after repetitive loading: a preliminary report. Osteoarthritis Cartilage 2002;10(1):71-81.
43. Lin PM, Chen CT, Torzilli PA. Increased stromelysin-1 (MMP-3), proteoglycan degradation (3B3- and 7D4) and collagen damage in cyclically load-injured articular cartilage. Osteoarthritis Cartilage 2004;12(6):485-96.
44. Sakkas LI, Scanzello C, Johanson N, et al. T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol 1998;5(4):430-7.
45. Moos V, Fickert S, Muller B, Weber U, Sieper J. Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. J Rheumatol 1999;26(4):870-9.
46. Caron JP, Fernandes JC, Martel-Pelletier J, et al. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum 1996;39(9):1535-44.
47. van de Loo FA, Joosten LA, van Lent PL, Arntz OJ, van den Berg WB. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum 1995;38(2):164-72.
48. Kaneyama K, Segami N, Nishimura M, Suzuki T, Sato J. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders. Br J Oral Maxillofac Surg 2002;40(5):418-23.
49. Segami N, Miyamaru M, Nishimura M, Suzuki T, Kaneyama K, Murakami K. Does joint effusion on T2 magnetic resonance images reflect synovitis? Part 2. Comparison of concentration levels of proinflammatory cytokines and total protein in synovial fluid of the temporomandibular joint with internal derangements and osteoarthrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94(4):515-21.
50. Nishimura M, Segami N, Kaneyama K, Suzuki T, Miyamara M. Proinflammatory cytokines and arthroscopic findings of patients with internal derangement and osteoarthritis of the temporomandibular joint. Br J Oral Maxillofac Surg 2002;40(1):68-71.
51. Dougados M, Nguyen M, Berdah L, Mazieres B, Vignon E, Lequesne M. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum 2001;44(11):2539-47.
52. Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000;343(22):1586-93.
53. Genovese MC, Bathon JM, Martin RW, et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum 2002;46(6):1443-50.
54. Yokota S. Interleukin 6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis. Curr Opin Rheumatol 2003;15(5):581-6.
55. Iwamoto M, Nara H, Hirata D, Minota S, Nishimoto N, Yoshizaki K. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease. Arthritis Rheum 2002;46(12):3388-9.
56. Wolfe F. The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip. J Rheumatol 1997;24(8):1486-8.
57. Sharif M, Elson CJ, Dieppe PA, Kirwan JR. Elevated serum C-reactive protein levels in osteoarthritis. Br J Rheumatol 1997;36(1):140-1.
58. Otterness IG, Swindell AC, Zimmerer RO, Poole AR, Ionescu M, Weiner E. An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthritis Cartilage 2000;8(3):180-5.
59. Conrozier T, Carlier MC, Mathieu P, et al. Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study [in process citation]. Ann Rheum Dis 2000;59(10):828-31.
60. Conrozier T, Chappuis-Cellier C, Richard M, Mathieu P, Richard S, Vignon E. Increased serum C-reactive protein levels by immunonephelometry in patients with rapidly destructive hip osteoarthritis. Rev Rhum Engl Ed 1998;65(12):759-65.
61. Spector TD, Hart DJ, Nandra D, et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997;40(4):723-7.
62. Sharif M, Shepstone L, Elson CJ, Dieppe PA, Kirwan JR. Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee. Ann Rheum Dis 2000;59(1):71-4.
63. Sowers M, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L. C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthritis Cartilage 2002;10(8):595-601.